First Time Loading...

Palla Pharma Ltd
ASX:PAL

Watchlist Manager
Palla Pharma Ltd Logo
Palla Pharma Ltd
ASX:PAL
Watchlist
Price: 0.295 AUD Market Closed
Updated: May 21, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

49.9m
-26%
Assets
Growth Rates:
1 Year
-42%
3 Years
-34%
5 Years
+15%
7 Years
-
10 Years
-
29.8m
-5%
Liabilities
Growth Rates:
1 Year
+22%
3 Years
+22%
5 Years
-1%
7 Years
-
10 Years
-
20.1m
-44%
Equity
Growth Rates:
1 Year
-67%
3 Years
-61%
5 Years
+50%
7 Years
-
10 Years
-

Balance Sheet Decomposition
Palla Pharma Ltd

49.9m
Assets
29.8m
Liabilities
49.9m
Assets
29.8m
Liabilities
Current Assets 30.7m
Cash & Short-Term Investments 897.3k
Receivables 3.6m
Other Current Assets 26.2m
Non-Current Assets 19.2m
PP&E 16.2m
Intangibles 2.7m
Other Non-Current Assets 273.1k
Current Liabilities 28.1m
Accounts Payable 11.5m
Accrued Liabilities 1.5m
Short-Term Debt 44.9k
Other Current Liabilities 15m
Non-Current Liabilities 1.7m
Long-Term Debt 457.6k
Other Non-Current Liabilities 1.3m

Balance Sheet
Palla Pharma Ltd

Rotate your device to view
Balance Sheet
Currency: AUD
Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020
Assets
Cash & Cash Equivalents
0
0
0
0
0
1
4
2
2
1
Cash
0
0
0
0
0
0
4
2
2
1
Cash Equivalents
0
0
0
0
0
1
0
0
0
0
Short-Term Investments
1
1
0
0
0
0
0
0
0
0
Total Receivables
1
1
1
0
1
4
9
15
18
8
Accounts Receivables
0
1
1
0
0
4
9
14
17
7
Other Receivables
0
0
0
0
1
0
1
2
0
1
Inventory
4
6
5
0
8
7
16
19
22
27
Other Current Assets
2
2
4
3
1
1
4
3
1
2
Total Current Assets
7
11
11
3
11
13
34
39
43
37
PP&E Net
19
20
26
0
29
28
27
28
27
24
PP&E Gross
19
20
26
0
29
28
27
28
27
24
Accumulated Depreciation
3
5
10
0
18
18
20
22
25
17
Intangible Assets
3
3
3
0
2
2
2
1
3
4
Goodwill
0
0
0
0
0
0
14
14
14
0
Note Receivable
0
0
0
0
0
0
0
0
0
0
Long-Term Investments
0
0
0
0
0
0
0
0
0
0
Other Long-Term Assets
0
0
0
0
0
0
0
2
2
2
Other Assets
0
0
0
0
0
0
14
14
14
0
Total Assets
29
N/A
33
+14%
40
+20%
0
N/A
42
N/A
43
+4%
77
+78%
84
+9%
90
+7%
67
-25%
Liabilities
Accounts Payable
2
3
1
0
5
3
7
8
7
7
Accrued Liabilities
0
0
0
0
1
1
1
2
2
2
Short-Term Debt
0
0
0
0
0
0
0
0
0
1
Current Portion of Long-Term Debt
25
23
18
18
0
1
13
0
0
4
Other Current Liabilities
2
0
1
0
1
0
2
2
2
2
Total Current Liabilities
29
26
20
18
7
5
23
11
11
16
Long-Term Debt
4
4
9
0
14
27
0
23
5
13
Deferred Income Tax
0
0
0
0
0
0
0
0
0
0
Other Liabilities
0
0
0
0
0
0
0
0
2
2
Total Liabilities
33
N/A
31
-8%
29
-6%
0
N/A
21
N/A
33
+56%
24
-27%
34
+46%
18
-47%
31
+72%
Equity
Common Stock
33
52
83
0
118
122
181
181
211
211
Retained Earnings
37
50
72
0
97
111
128
132
140
175
Other Equity
0
0
0
0
0
0
0
0
0
0
Total Equity
4
N/A
3
N/A
12
+319%
0
N/A
21
N/A
11
-48%
53
+397%
49
-7%
71
+45%
36
-49%
Total Liabilities & Equity
29
N/A
33
+14%
40
+20%
0
N/A
42
N/A
43
+4%
77
+78%
84
+9%
90
+7%
67
-25%
Shares Outstanding
Common Shares Outstanding
31
41
47
0
59
59
91
91
132
132

See Also

Summary
PAL intrinsic value, competitors valuation, and company profile.
DCF Valuation
PAL stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PAL stock valuation using valuation multiples.
Wall Street Estimates
PAL price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PAL stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 139,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.